Effect of a cardiac telerehabilitation program during COVID-19 associated social isolation

João Paulo Prado1, Giovane Galdino1

  • 1Institute of Motricity Sciences, Federal University of Alfenas, Alfenas, Minas Gerais, Brazil.

Insights

Conventional cardiac rehabilitation (CCR) improved outcomes more than cardiac telerehabilitation (CTR) during COVID-19 social isolation. CTR, however, helped stabilize patients with cardiovascular diseases.

Area of Science:

  • Cardiology
  • Rehabilitation Medicine
  • Public Health

Background:

  • Social isolation during the COVID-19 pandemic posed challenges for patients with cardiovascular diseases (CVDs).
  • Maintaining rehabilitation programs is crucial for managing CVDs and improving patient quality of life.

Purpose of the Study:

  • To compare the effectiveness of conventional cardiac rehabilitation (CCR) versus cardiac telerehabilitation (CTR) for patients with CVDs during COVID-19-related social isolation.
  • To assess the impact of these rehabilitation strategies on clinical outcomes and quality of life.

Main Methods:

  • A retrospective cohort study involving 58 patients with stable CVDs.
  • Participants were divided into three groups: CCR (n=20), CTR (n=18), and a control group (n=20).
  • Outcomes including body mass index, quality of life, and blood pressure were compared between groups and against baseline.

Main Results:

  • CCR significantly reduced body mass index and improved quality of life (physical, vitality, emotional aspects) compared to baseline.
  • CTR did not show significant improvements in these clinical outcomes compared to baseline.
  • CTR was effective in preventing clinical deterioration and stabilizing blood pressure and quality of life.

Conclusions:

  • Conventional cardiac rehabilitation demonstrated superior clinical improvement and quality of life benefits compared to cardiac telerehabilitation.
  • Cardiac telerehabilitation served as a vital tool for maintaining patient stability, particularly blood pressure and quality of life, during the COVID-19 pandemic's social isolation period.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
18
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
16